Dec 16, 2020

Medscape recently launched “Gene Therapy and Hemophilia: What Every Nurse Should Know,” the  latest educational activity in their “Clinical  Advances in Gene Therapy for Hemophilia” series. Presented through a collaboration between Medscape and the National Hemophilia Foundation, the series includes various discussions relevant to the latest data on gene therapy as well as the practicalities associated with using gene therapy for hemophilia.

The goal of “Gene Therapy and Hemophilia: What Every Nurse Should Know,” is to improve recognition of how gene therapy will affect the routine care for patients with hemophilia. It is designed for nurses, nurse practitioners, and other healthcare professionals that are involved in the management of patients with hemophilia.

Participants who complete this activity will:

  • Have increased knowledge regarding the
    • Evolution in patient management associated with gene therapy in the care of patients with hemophilia
    • Implications of gene therapy on the role of the nurse in providing hemophilia care

 

Gene Therapy and Hemophilia: What Every Nurse Should Know
Authors: Emily Bisson, APRN, CPNP; Susan Lattimore, RN, GCPH
CE Released: 12/11/2020
Valid for credit through: 12/11/2021

 

If you are already registered with Medscape follow this link to “Gene Therapy and Hemophilia: What Every Nurse Should Know.”

Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage.

If you are not already registered, go to Medscape.org where registration is straightforward and free of charge.